PortfoliosLab logo
INCY vs. ILMN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between INCY and ILMN is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

INCY vs. ILMN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Incyte Corporation (INCY) and Illumina, Inc. (ILMN). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

INCY:

0.30

ILMN:

-0.72

Sortino Ratio

INCY:

0.58

ILMN:

-0.93

Omega Ratio

INCY:

1.08

ILMN:

0.89

Calmar Ratio

INCY:

0.13

ILMN:

-0.36

Martin Ratio

INCY:

0.60

ILMN:

-1.28

Ulcer Index

INCY:

14.18%

ILMN:

24.25%

Daily Std Dev

INCY:

34.83%

ILMN:

42.22%

Max Drawdown

INCY:

-98.54%

ILMN:

-96.14%

Current Drawdown

INCY:

-61.37%

ILMN:

-85.16%

Fundamentals

Market Cap

INCY:

$11.42B

ILMN:

$11.99B

EPS

INCY:

$0.20

ILMN:

-$6.08

PEG Ratio

INCY:

0.11

ILMN:

0.62

PS Ratio

INCY:

2.59

ILMN:

2.76

PB Ratio

INCY:

3.11

ILMN:

5.06

Total Revenue (TTM)

INCY:

$4.41B

ILMN:

$3.30B

Gross Profit (TTM)

INCY:

$4.07B

ILMN:

$2.19B

EBITDA (TTM)

INCY:

$406.83M

ILMN:

-$741.00M

Returns By Period

In the year-to-date period, INCY achieves a -14.61% return, which is significantly higher than ILMN's -43.31% return. Over the past 10 years, INCY has outperformed ILMN with an annualized return of -5.78%, while ILMN has yielded a comparatively lower -8.98% annualized return.


INCY

YTD

-14.61%

1M

3.71%

6M

-29.26%

1Y

11.16%

5Y*

-9.46%

10Y*

-5.78%

ILMN

YTD

-43.31%

1M

1.31%

6M

-49.86%

1Y

-29.54%

5Y*

-24.78%

10Y*

-8.98%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

INCY vs. ILMN — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INCY
The Risk-Adjusted Performance Rank of INCY is 5656
Overall Rank
The Sharpe Ratio Rank of INCY is 6161
Sharpe Ratio Rank
The Sortino Ratio Rank of INCY is 5555
Sortino Ratio Rank
The Omega Ratio Rank of INCY is 5454
Omega Ratio Rank
The Calmar Ratio Rank of INCY is 5454
Calmar Ratio Rank
The Martin Ratio Rank of INCY is 5757
Martin Ratio Rank

ILMN
The Risk-Adjusted Performance Rank of ILMN is 1616
Overall Rank
The Sharpe Ratio Rank of ILMN is 1414
Sharpe Ratio Rank
The Sortino Ratio Rank of ILMN is 1414
Sortino Ratio Rank
The Omega Ratio Rank of ILMN is 1717
Omega Ratio Rank
The Calmar Ratio Rank of ILMN is 2424
Calmar Ratio Rank
The Martin Ratio Rank of ILMN is 1313
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

INCY vs. ILMN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Incyte Corporation (INCY) and Illumina, Inc. (ILMN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current INCY Sharpe Ratio is 0.30, which is higher than the ILMN Sharpe Ratio of -0.72. The chart below compares the historical Sharpe Ratios of INCY and ILMN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

INCY vs. ILMN - Dividend Comparison

Neither INCY nor ILMN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

INCY vs. ILMN - Drawdown Comparison

The maximum INCY drawdown since its inception was -98.54%, roughly equal to the maximum ILMN drawdown of -96.14%. Use the drawdown chart below to compare losses from any high point for INCY and ILMN. For additional features, visit the drawdowns tool.


Loading data...

Volatility

INCY vs. ILMN - Volatility Comparison

The current volatility for Incyte Corporation (INCY) is 11.18%, while Illumina, Inc. (ILMN) has a volatility of 13.74%. This indicates that INCY experiences smaller price fluctuations and is considered to be less risky than ILMN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

INCY vs. ILMN - Financials Comparison

This section allows you to compare key financial metrics between Incyte Corporation and Illumina, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


600.00M700.00M800.00M900.00M1.00B1.10B1.20B20212022202320242025
1.05B
1.10B
(INCY) Total Revenue
(ILMN) Total Revenue
Values in USD except per share items

INCY vs. ILMN - Profitability Comparison

The chart below illustrates the profitability comparison between Incyte Corporation and Illumina, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%70.0%80.0%90.0%100.0%20212022202320242025
93.1%
65.9%
(INCY) Gross Margin
(ILMN) Gross Margin
INCY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Incyte Corporation reported a gross profit of 979.70M and revenue of 1.05B. Therefore, the gross margin over that period was 93.1%.

ILMN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Illumina, Inc. reported a gross profit of 728.00M and revenue of 1.10B. Therefore, the gross margin over that period was 65.9%.

INCY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Incyte Corporation reported an operating income of 205.17M and revenue of 1.05B, resulting in an operating margin of 19.5%.

ILMN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Illumina, Inc. reported an operating income of 175.00M and revenue of 1.10B, resulting in an operating margin of 15.9%.

INCY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Incyte Corporation reported a net income of 158.20M and revenue of 1.05B, resulting in a net margin of 15.0%.

ILMN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Illumina, Inc. reported a net income of 187.00M and revenue of 1.10B, resulting in a net margin of 16.9%.